Skip to content

Avantor AVTR Free cash flow margin

Free cash flow margin at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
15.7%-2.1pp
Danaher logo
DanaherDHR
21.4%+0.8pp
Agilent Technologies logo
Agilent TechnologiesA
15%-2.9pp
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
14.2%+3.6pp
Element Solutions logo
Element SolutionsESI
4.3%-6.6pp
Westlake logo
WestlakeWLK
-4.6%-5.3pp

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Calculated from Avantor’s reported figures.

Based on trailing twelve months.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's free cash flow margin?
Avantor (AVTR) reported free cash flow margin of 6.7% in Q1 2026.
How has Avantor's free cash flow margin changed year-over-year?
Avantor's free cash flow margin decreased by 32.8% year-over-year, from 10% to 6.7%.
What is the long-term trend for Avantor's free cash flow margin?
Over 5 years (2020 to 2025), Avantor's free cash flow margin has grown at a -11.1% compound annual growth rate (CAGR), from 13.6% to 7.6%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.